Enhanced osseous integration of human trabecular allografts following surface modification with bioactive lipids.
Enhanced osseous integration of human trabecular allografts following surface modification with bioactive lipids.
复制标题
DOI:
10.1007/s13346-015-0244-0
复制
发表时间:
2016-04
影响因子:
5.4
通讯作者:
Botchwey E
中科院分区:
文献类型:
--
作者:
Wang T;Krieger J;Huang C;Das A;Francis MP;Ogle R;Botchwey E
In this study, we used extracellular matrix (ECM) gels and human bone allograft as matrix vehicles to deliver the sphingolipid growth factor FTY720 to rodent models of tibial fracture and a critical-sized cranial defect. We show that FTY720 released from injectable ECM gels may accelerate callous formation and resolution and bone volume in a mouse tibial fracture model. We then show that FTY720 binds directly to human trabecular allograft bone and releases over 1 week in vitro. Rat critical-sized cranial defects treated with FTY720-coated grafts show increases in vascularization and bone deposition, with histological and micro-computed topography (microCT) evidence of enhanced bone formation within the graft and defect void. Immunohistochemical analysis suggests that osteogenesis within FTY720-coated grafts is associated with reduced CD68+ macrophage infiltration and recruitment of CD29+ bone progenitor cells. Matrix binding of FTY720 thus represents a promising and robust bone regeneration strategy with potential clinical translatability.